News
Despite being on the market for less than three years, GLP-1 medicines, Mounjaro and Zepbound, became key top-line drivers for Lilly, with demand rising rapidly. Mounjaro and Zepbound generated ...
Lilly’s stock has risen 5.6% so far this year compared with the industry ’s increase of 2.9%. The stock has also outperformed the sector and S&P 500 index, as seen in the chart below.
6d
Investor's Business Daily on MSNMercadoLibre Stock Is Up 50% This Year And Approaching A Buy PointTop-rated e-commerce and payments giant MercadoLibre is trading 3% below an entry from a flat base after a 50% gain in 2025.
During the first quarter of 2025, the company's revenue rose by 50% year over year, to $927 million. And while that may seem high, it hasn't been out of the norm for the business of late.
During the first quarter of 2025, the company's revenue rose by 50% year over year, to $927 million. And while that may seem high, it hasn't been out of the norm for the business of late.
Even with the stock's resounding three-year gain, its valuation has decreased when looking at price-to-free cash flow (P/FCF) ...
Ford shares jumped Tuesday after the automaker reported a big jump in U.S. sales and an increase in market share in the ...
As Opening Bell Daily has reported, July tends to be the strongest month in post-election years, which have seen an average ...
Having almost reached our upside target of 25600 levels on Thursday, Nifty could now advance towards the next upper ...
Robinhood stock price has surged this year as investors cheered the company’s entry into tokenized assets. HOOD jumped to a ...
A weakening US dollar, too, has fueled stocks. According to Ulrike Hoffmann-Burchardi, CIO of global equities for UBS Global Wealth, a depreciating dollar will persist in the second half of the year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results